There were three great scientific horse races in the last century.
The first two, the race to the moon and the race to split the atom have been widely reported. The race to sequence the human genome seems to remain slightly less well understood by the public, in spite of its critical importance to the world of medicine.
The starting pistol was fired in 1989 when the NIH, the Wellcome Trust and a number of other groups agreed to fund the $3 billion dollar Human Genome Project (HGP) which was forecast to take fifteen years to complete. The sample of DNA which contained 3.3 billion pairs was broken in to strips of 150,000 pairs. Bacteria were used to replicate the strips and they were sent to labs around the world to be painstakingly decoded. This was one of the most ambitious scientific projects in our history and at every step along the way the information was uploaded on to the internet for free for scientists the world over to research in whatever way they pleased. The project promised to provide the groundwork for the cures of countless diseases and the roadmap of the human genome was to be available for free, in full on the internet, with new data released every single day.
In 1998 Craig Venter, a disaffected NIH scientist broke away and announced that his firm, Celera, was going head to head with the HGP in a separate bid to sequence the genome, using his new method. He aimed to do this for a tenth of the price and within a fraction of the time by effectively shattering the genome in to tiny pieces and using a faster technique to fit the puzzle back together.
This created a bitter controversy. Many argued that the faster technique was to take full advantage of the freely available HGP data. It was argued that not only was Celera attempting to undercut the largest humanitarian operation of all time and beat it at its own game, with its own pack of cards, Celera intended to patent everything it found in the process. Once news of this leaked every bio-tech company, hedge fund and banking consortium under the sun wanted a slice of the pie.
The irony of the situation was the Venter had tried desperately for his project to be a part of the public project and fully intended his data to be made public. Unfortunately Venter was forced to resign to being funded by investors, who of course have the sole objective of turning a profit. Venter’s bitter fights with his peers and overlords are described in Venter’s autobiography:
“I still felt trapped by constant legal hassles as HGS blindly went on attempting to patent the data flooding from my institute, whether they had a use for it or not. This was crazy, something had to give”.
Pretty soon Celera had filed patent applications on 6,500 whole or partial human genes. The company was well on its way in the process of patenting a great number of the very building blocks that make us human and the possible keys to beating diseases and infections ranging from HIV to the common cold. Celera wasn’t the only horse in the race however; patent trolls began filing DNA patents on a daily basis, based on publicly available data that was being released every night. Two other companies alone filed a further 6,300 patents each. Venter describes how “while my many critics were obsessed with the release of the Celera data, the publicly funded labs were heedlessly dumping sequences into public databases that the pharmaceutical companies were gleefully downloading nightly so they could file patents on them. This naïve policy… had precisely the opposite effect: Gene patents were filed sooner and faster, and almost all were based on government data, not Celera’s”.
Both Celera and the patent trolls had to duck for cover to escape the flack from all sides. All sides except the side of the banks that is. Celera’s stock price rapidly skyrocketed from $8 a share to $500 to share.
Things finally peaked when rumours surfaced that Celera was about to beat the HGP in the race to sequence the genome. Could it be possible that the whole genome was about to be reconstructed, only to be torn apart and patented bit by bit by one company? Wall Street went crazy, if this was true this would be the biggest, baddest, gamble in history and everyone wanted in. In the end President Clinton himself had to go on TV to tell everyone to calm down:
“in the strongest possible terms our genome, the book in which all human life is written, belongs to every member of the human race”
To sighs of relief from scientists and non-bankers everywhere Clinton asserted that no-one was going to patent the Genome. DNA was not for sale. Predictably enough, the bankers pulled out faster than a priest caught doing the bad thing. The Nasdaq experienced the second biggest crash in history losing a mammoth $50 Billion in 2 days on biotech stock alone. Celera tumbled from a listing of 47 to 142 on the New York Stock Exchange.
The Latest Bing News on:
Patent trolls
- Patent Trolls Threaten Floridian Seniors’ Access to the Interneton May 8, 2024 at 5:04 am
By Saul Anuzis Like Americans across the country, Florida’s senior citizens rely on their smartphones and laptops to access the critical broadband infrastruc ...
- Activision to pay $23.4m for patent infringementon May 7, 2024 at 8:21 am
A jury has ruled that Activision Blizzard will pay tech incubator Acceleration Bay $23.4 million for patent infringement. As reported by Law.com, the May 3 ruling comes after the incubator began its ...
- 5 Steps to Patent an Ideaon May 6, 2024 at 4:59 pm
Think you've got a million-dollar idea? You're not alone. There's always a few people out there at any moment, convinced they've got the next big app or the next popular product, while ...
- New Data Show There Is a Problem with the U.S. Patent System—But It’s Not Patent Trollson May 6, 2024 at 4:15 am
If the headlines are to be believed, every aspect of American life, from farming to football, is under threat due to excessive patent litigation. While these anecdotes may seem compelling, it is ...
- Trade secret claim still viable despite disclosure in patent applicationon May 3, 2024 at 9:02 am
May 03, 2024 - It is well established that, once a patent issues, the subject matter contained in the patent is publicly available and therefore no longer entitled to trade secret protection.
- All Galaxy smartphones affected: Samsung loses patent lawsuiton April 26, 2024 at 9:09 am
The Chinese company Datang has won in full against Samsung in the first instance. There is a threat of a sales ban, but Samsung is likely to take legal action.
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- Senator introduces legislation targeting patent trollson April 23, 2024 at 3:43 am
PCWorld helps you navigate the PC ecosystem to find the products you want and the advice you need to get the job done.
- Report: Obama to announce measures against patent trollson April 23, 2024 at 3:33 am
After months on the market, Windows 8 tablets have yet to rack up the sales Microsoft and PC vendors were originally hoping for. But on Monday Taiwanese PC maker Acer showed off what could be the ...
- How two small Texas towns became the patent-law centre of Americaon April 15, 2024 at 5:00 pm
Around the same period, “it also happened that there was an explosion of patent-troll litigation,” says Paul Gugliuzza of Temple University, referring to plaintiffs who own bad patents and ...
The Latest Google Headlines on:
Patent trolls
[google_news title=”” keyword=”patent trolls” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Patents
- Design Patents – What is comparison prior art?on May 9, 2024 at 4:30 am
Last month, we discussed issues in obtaining a design patent. This month, we look at issues in enforcing the design patent. Remember that utility patents and design patents are separate and distinct and protect different things.
- How sham patents are hurting the pharma industryon May 7, 2024 at 3:09 am
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
The Latest Google Headlines on:
Patents
[google_news title=”” keyword=”patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]